Survival after pathological complete response following neoadjuvant chemotherapy <i>versus</i> chemoradiotherapy for oesophageal squamous cell carcinoma
Among patients who achieved pCR, postoperative outcomes varied considerably by neoadjuvant treatment modality. The markedly favourable prognosis associated with pCR after NAC suggests that these patients may represent an optimal candidate cohort for future evaluation of surgery-avoidance and watch-and-wait strategies.
Authors
- T Aparicio
- Jun Okui (ORCID: https://orcid.org/0000-0002-5226-1347)
- Koji Kato (ORCID: https://orcid.org/0000-0002-7397-1575)
- K. Nagashima
- T. Tsushima
- Marie Nilsson
- Shaoyuan Zhang
- Y Sato
- Satoru Matsuda
- Guillaume Piessen
- Thomas Ruhstaller
- Yuko Kitagawa
- Bianca Mostert
- Peter Thuss-Patience
- Hirofumi Kawakubo
- Charlène van der Zijden
- Fredrik Klevebro
- Bas P L Wijnhoven
- Lijie Tan
- Hiroya Takeuchi
Institutions
- Karolinska University Hospital (SE)
- Inserm (FR)
- Sun Yat-sen University (CN)
- University of Basel (CH)
- Keio University (JP)
- Université Paris Cité (FR)
- Université de Lille (FR)
- Fudan University (CN)
- Karolinska Institutet (SE)
- Hamamatsu University School of Medicine (JP)
- Shizuoka Cancer Center (JP)
- National Cancer Center (US)
- Keio University Hospital (JP)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Hôpital Saint-Louis (FR)
- Swiss Group For Clinical Cancer Research (CH)
- Erasmus MC Cancer Institute (NL)
- CANTHER - Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers (FR)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- British journal of surgery
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1093/bjs/znag012
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00